Preclinical reports counsel that retatrutide might impact obesity-involved most cancers progression. Inside a study led by Marathe et al., retatrutide-induced weight-loss decreased tumor engraftment, delayed tumor onset, and substantially attenuated tumor progress in pancreatic and lung most cancers products, with better tumor suppression when comp